England’s 20th century NHS needs 21st century decision-making
This article was originally published in Clinica
Reform of the NHS in England, as proposed some 15 months ago shortly after the UK coalition government formed, will return to the headlines tomorrow and Wednesday when the amended Health and Social Care Bill is debated in the House of Commons, probably for the final time.
You may also be interested in...
In 2018, the top 100 publicly listed and reportable medical device technology companies had global sales spanning from over $30bn to some $100m in the lower reaches. As the latest In Vivo Medtech 100 ranking shows, many of the major changes in value sales were linked to company restructurings. But there were some impressive organic gains too.
ConMed Corp. is company of two halves ̶ general surgery and orthopedics – and is readying itself for a renewed assault on these two markets on the back of a technology pipeline, targeted acquisitions and a new growth-winning culture, says CFO Todd Garner.
The disruptive medtech M&A of recent years was not matched in the past year for volume, but there were isolated outbreaks of major activity, as shown in our company rankings.